Publications by authors named "Nicholas P Morris"

Claim this Profile
P
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
Michael D Oberst, Catherine Augé, Chad Morris, Stacy Kentner, Kathy Mulgrew, Nicholas P Morris

Mol Cancer Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.
Guangjie Yu, Yuhuan Li, Zhihua Cui, Nicholas P Morris, Andrew D Weinberg

Sci Rep· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Science gone translational: the OX40 agonist story.
Andrew D Weinberg, Nicholas P Morris, Magdalena Kovacsovics-Bankowski, Walter J Urba, Brendan D Curti

Immunol Rev· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain.
Nicholas P Morris, Carmen Peters, Ryan Montler, Hong-Ming Hu, Brendan D Curti

Mol Immunol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I.
Chien-Hui Hung, Laurel Thomas, Carl E Ruby, Katelyn M Atkins, Nicholas P Morris

Cell Host Microbe· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis